Market Cap ₹66501 Cr.
Stock P/E 155.4
P/B 19.8
Current Price ₹7797.6
Book Value ₹ 394.4
Face Value 10
52W High ₹8658.9
Dividend Yield 0.15%
52W Low ₹ 3857.3
Linde India Ltd is engaged inside the gases business. The Company is engaged in the production of industrial and medical gases and the construction of cryogenic and noncryogenic air separation plants. The Company's business operating segments include Gases, Related Products and Project Engineering. The Gases and Related Products section consists of pipeline gasoline resources to industrial clients, supply of liquefied gases to mid-demand needs, and compressed gas supply in cylinders for meeting smaller demand for gases throughout fabrication, manufacturing and construction industry. The Project Engineering segment is engaged in the commercial enterprise of designing and engineering, deliver, installation, and commissioning of tonnage air separation devices, nitrogen plants, hydrogen pressure swing adsorption flora, compressed air structures, and gas distribution structures. The Project Engineering Division manufactures cryogenic vessels, steam bath vaporizers, and containerized micro flowers.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 507 | 644 | 534 | 588 | 686 | 697 | 630 | 721 | 711 | 706 |
| Other Income | 11 | 21 | 14 | 11 | 35 | 19 | 22 | 18 | 19 | 22 |
| Total Income | 518 | 666 | 548 | 599 | 721 | 716 | 652 | 739 | 730 | 728 |
| Total Expenditure | 377 | 496 | 403 | 453 | 542 | 529 | 444 | 557 | 538 | 520 |
| Operating Profit | 141 | 170 | 146 | 145 | 179 | 187 | 207 | 182 | 192 | 208 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 45 | 46 | 46 | 46 | 44 | 48 | 66 | 49 | 50 | 51 |
| Exceptional Income / Expenses | 0 | -19 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 95 | 103 | 99 | 98 | 134 | 138 | 140 | 132 | 141 | 156 |
| Provision for Tax | 33 | 37 | 35 | -74 | 46 | 31 | 42 | 34 | 35 | 39 |
| Profit After Tax | 62 | 66 | 64 | 172 | 88 | 107 | 99 | 98 | 107 | 117 |
| Adjustments | 1 | 2 | 2 | -0 | 3 | 3 | 1 | 2 | 2 | 3 |
| Profit After Adjustments | 64 | 68 | 66 | 172 | 91 | 110 | 99 | 100 | 109 | 120 |
| Adjusted Earnings Per Share | 7.5 | 8 | 7.7 | 20.2 | 10.7 | 12.9 | 11.6 | 11.7 | 12.7 | 14.1 |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 | TTM |
|---|---|---|---|---|---|---|---|---|
| Net Sales | 1825 | 2033 | 2192 | 1762 | 1471 | 2112 | 3136 | 2768 |
| Other Income | 31 | 8 | 9 | 22 | 33 | 56 | 105 | 81 |
| Total Income | 1857 | 2041 | 2201 | 1783 | 1504 | 2167 | 3241 | 2849 |
| Total Expenditure | 1539 | 1710 | 1866 | 1348 | 1096 | 1566 | 2373 | 2059 |
| Operating Profit | 318 | 331 | 335 | 436 | 407 | 601 | 868 | 789 |
| Interest | 116 | 116 | 103 | 86 | 6 | 3 | 6 | 4 |
| Depreciation | 195 | 202 | 199 | 177 | 176 | 181 | 253 | 216 |
| Exceptional Income / Expenses | 0 | -6 | 0 | 841 | 2 | 275 | 0 | 0 |
| Profit Before Tax | 16 | 13 | 39 | 1013 | 229 | 698 | 618 | 569 |
| Provision for Tax | -3 | -3 | 14 | 286 | 78 | 191 | 80 | 150 |
| Profit After Tax | 19 | 16 | 26 | 727 | 151 | 507 | 538 | 421 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 |
| Profit After Adjustments | 19 | 16 | 26 | 727 | 151 | 507 | 538 | 428 |
| Adjusted Earnings Per Share | 2.2 | 1.9 | 3 | 85.3 | 17.7 | 59.5 | 63.1 | 50.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 48% | 21% | 9% | 0% |
| Operating Profit CAGR | 44% | 26% | 21% | 0% |
| PAT CAGR | 6% | -10% | 102% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 95% | 64% | 72% | 39% |
| ROE Average | 18% | 15% | 18% | 13% |
| ROCE Average | 21% | 20% | 22% | 17% |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 |
|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 1441 | 1451 | 1462 | 2172 | 2234 | 2715 | 3140 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 990 | 776 | 417 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 164 | 165 | 178 | 294 | 342 | 933 | 870 |
| Total Current Liabilities | 1013 | 1020 | 1364 | 784 | 710 | 875 | 1066 |
| Total Liabilities | 3608 | 3412 | 3420 | 3250 | 3286 | 4523 | 5077 |
| Fixed Assets | 2573 | 2498 | 2162 | 2035 | 1989 | 1869 | 1762 |
| Other Non-Current Assets | 266 | 240 | 218 | 258 | 211 | 787 | 1116 |
| Total Current Assets | 769 | 675 | 765 | 902 | 1041 | 1845 | 2181 |
| Total Assets | 3608 | 3412 | 3420 | 3250 | 3286 | 4523 | 5077 |
| #(Fig in Cr.) | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 |
|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 21 | 106 | 37 | 125 | 240 | 324 | 983 |
| Cash Flow from Operating Activities | 293 | 252 | 376 | 327 | 339 | 589 | 629 |
| Cash Flow from Investing Activities | -128 | -59 | -73 | 981 | -54 | 98 | -306 |
| Cash Flow from Financing Activities | -80 | -261 | -216 | -1193 | -201 | -28 | -119 |
| Net Cash Inflow / Outflow | 85 | -68 | 87 | 115 | 84 | 659 | 203 |
| Closing Cash & Cash Equivalent | 106 | 37 | 125 | 240 | 324 | 983 | 1187 |
| # | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Mar 2023 |
|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 2.23 | 1.9 | 3.01 | 85.27 | 17.72 | 59.47 | 63.09 |
| CEPS(Rs) | 25.14 | 25.58 | 26.36 | 106.05 | 38.35 | 80.74 | 92.74 |
| DPS(Rs) | 0.75 | 1 | 1.5 | 10 | 3 | 13.5 | 12 |
| Book NAV/Share(Rs) | 168.96 | 170.09 | 171.41 | 254.67 | 261.98 | 318.33 | 368 |
| Core EBITDA Margin(%) | 14.49 | 15.29 | 14.84 | 23.51 | 25.48 | 25.84 | 24.33 |
| EBIT Margin(%) | 6.64 | 6.14 | 6.48 | 62.39 | 15.97 | 33.19 | 19.9 |
| Pre Tax Margin(%) | 0.8 | 0.63 | 1.8 | 57.49 | 15.54 | 33.05 | 19.72 |
| PAT Margin (%) | 0.96 | 0.77 | 1.17 | 41.28 | 10.27 | 24.02 | 17.16 |
| Cash Profit Margin (%) | 10.83 | 10.31 | 10.26 | 51.34 | 22.23 | 32.6 | 25.22 |
| ROA(%) | 0.53 | 0.46 | 0.75 | 21.81 | 4.62 | 12.99 | 11.21 |
| ROE(%) | 1.32 | 1.12 | 1.76 | 40.02 | 6.86 | 20.5 | 18.38 |
| ROCE(%) | 4.55 | 4.62 | 5.27 | 44.49 | 10.41 | 28.33 | 21.31 |
| Receivable days | 65.8 | 61.23 | 59.74 | 77.43 | 98.01 | 71.76 | 52.38 |
| Inventory Days | 12.67 | 11.82 | 11.6 | 14.13 | 16.62 | 11.9 | 8.53 |
| Payable days | 446.54 | 375.72 | 267.84 | 300.78 | 435.88 | 276.09 | 164.27 |
| PER(x) | 158.97 | 281.08 | 226.26 | 7.77 | 54.83 | 41.88 | 63.9 |
| Price/Book(x) | 2.1 | 3.14 | 3.98 | 2.6 | 3.71 | 7.82 | 10.95 |
| Dividend Yield(%) | 0.21 | 0.19 | 0.22 | 1.51 | 0.31 | 0.54 | 0.3 |
| EV/Net Sales(x) | 2.39 | 2.85 | 3.14 | 3.13 | 5.41 | 9.59 | 10.59 |
| EV/Core EBITDA(x) | 13.71 | 17.5 | 20.57 | 12.66 | 19.53 | 33.69 | 38.23 |
| Net Sales Growth(%) | 0 | 11.38 | 7.8 | -19.61 | -16.5 | 43.56 | 48.47 |
| EBIT Growth(%) | 0 | -1.15 | 9.39 | 673.63 | -78.63 | 198.41 | -10.99 |
| PAT Growth(%) | 0 | -14.85 | 58.7 | 2730.37 | -79.22 | 235.69 | 6.08 |
| EPS Growth(%) | 0 | -14.85 | 58.7 | 2730.39 | -79.22 | 235.69 | 6.08 |
| Debt/Equity(x) | 1 | 0.88 | 0.82 | 0.05 | 0 | 0 | 0 |
| Current Ratio(x) | 0.76 | 0.66 | 0.56 | 1.15 | 1.47 | 2.11 | 2.05 |
| Quick Ratio(x) | 0.69 | 0.59 | 0.51 | 1.07 | 1.37 | 2.03 | 1.97 |
| Interest Cover(x) | 1.14 | 1.12 | 1.38 | 12.74 | 37.63 | 229.52 | 110.32 |
| Total Debt/Mcap(x) | 0.48 | 0.28 | 0.21 | 0.02 | 0 | 0 | 0 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.56 | 2.59 | 2.65 | 2.77 | 2.8 | 2.77 | 2.84 | 2.89 | 2.24 | 2.32 |
| DII | 8.27 | 8.32 | 7.97 | 7.77 | 7.8 | 8 | 7.77 | 7.44 | 7.22 | 7.45 |
| Public | 14.17 | 14.1 | 14.38 | 14.46 | 14.4 | 14.23 | 14.39 | 14.67 | 15.53 | 15.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 | 6.4 |
| FII | 0.22 | 0.22 | 0.23 | 0.24 | 0.24 | 0.24 | 0.24 | 0.25 | 0.19 | 0.2 |
| DII | 0.71 | 0.71 | 0.68 | 0.66 | 0.67 | 0.68 | 0.66 | 0.63 | 0.62 | 0.63 |
| Public | 1.21 | 1.2 | 1.23 | 1.23 | 1.23 | 1.21 | 1.23 | 1.25 | 1.32 | 1.3 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 | 8.53 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
| Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
|---|
You May Also Know About
